Back to results
US 10,441,641 B2Granted
Botulinum toxin and the treatment of primary disorders of mood and affect
AssigneeRevance Therapeutics, Inc.
InventorGary E. Borodic
Life of this patent
Estimating the term…
Abstract
A method of treating circadian rhythm disorders includes identifying a subject with a circadian rhythm disorder or at least one symptom of a circadian rhythm disorder and administering an effective amount of a composition comprising a botulinum toxin and a pharmaceutically acceptable carrier to said subject thereby reducing at least one symptom of a circadian rhythm disorder.
Claims9
A method for simultaneously treating both sleep disorder and depression comprising:
- (i) identifying a subject with both sleep disorder and depression;
- and
- (ii) administering an effective amount of a composition comprising a botulinum toxin immunotype A and a pharmaceutically acceptable carrier to the subject, thereby reducing at least one symptom of both sleep disorder and depression;
- wherein said sleep disorder is sleep onset insomnia or sleep maintenance insomnia.
1 more element
Dependencies are inferred from the claim text.